Skip to content

Single arm study of Xuanfei Baidu Recipe in treating common type of novel coronavirus pneumonia and truncating its severity

Single arm study of Xuanfei Baidu Recipe in treating common type of novel coronavirus pneumonia and truncating its severity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005994
Enrollment
Unknown
Registered
2022-05-11
Start date
2022-05-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia

Interventions

Xuanfei Baidu Recipe combined with Western Medicine:Xuanfei Baidu Recipe combined with Western Medicine

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the western medicine diagnostic criteria of the common type of coronavirus pneumonia; 2. TCM syndrome differentiation belongs to dampness-toxin stagnation lung; 3. Aged = 18 years old and = 80 years old, male or female; 4. Understand and agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with primary lung diseases, such as lung cancer, severe pulmonary interstitial fibrosis, chronic obstructive pulmonary disease, etc.; 2. Patients with severe primary diseases of heart, brain, liver, gastrointestinal tract, kidney, blood and endocrine system; 3. Patients who have received immunosuppressive therapy or organ transplantation in the past 6 months; 4. Patients with severe mental illness; 5. Pregnant and lactating women; 6. Patients who are allergic to the drugs used in this study, or who cannot cooperate with the medication and complete the relevant records due to various conditions; 7. Patients who are not suitable for participating in this clinical trial as judged by the researchers.

Design outcomes

Primary

MeasureTime frame
Biochemical indicators;Cure rate;Chest CT;Hospital stay;Nucleic acid conversion time;

Secondary

MeasureTime frame
TCM symptom score;Severe conversion rate;Time to fever subsidence;Case fatality rate;

Countries

China

Contacts

Public ContactZhou Bingduo
bingduozhou@163.com13301659115

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026